NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $31.48 -0.63 (-1.95%) Closing price 03:59 PM EasternExtended Trading$31.40 -0.09 (-0.28%) As of 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About USANA Health Sciences Stock (NYSE:USNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get USANA Health Sciences alerts:Sign Up Key Stats Today's Range$31.38▼$32.2550-Day Range$28.85▼$35.4052-Week Range$23.10▼$41.83Volume111,774 shsAverage Volume174,444 shsMarket Capitalization$575.21 millionP/E Ratio17.49Dividend YieldN/APrice Target$36.00Consensus RatingHold Company Overview USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Read More USANA Health Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks84th Percentile Overall ScoreUSNA MarketRank™: USANA Health Sciences scored higher than 84% of companies evaluated by MarketBeat, and ranked 175th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageUSANA Health Sciences has received no research coverage in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Earnings and Valuation3.8 / 5Proj. Earnings Growth17.96% Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 17.96% in the coming year, from $2.45 to $2.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 17.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.69.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 17.49, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.31.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.01. PEG Ratios around 1 indicate that a company is correctly valued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about USANA Health Sciences' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.73% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 7.62%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Sustainability and ESG3.3 / 5Environmental Score-2.01 Percentage of Shares Shorted6.73% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 7.62%, indicating that investor sentiment is improving significantly. News and Social Media1.7 / 5News Sentiment1.01 News SentimentUSANA Health Sciences has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for USANA Health Sciences this week, compared to 4 articles on an average week. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $151,982.00 in company stock.Percentage Held by InsidersOnly 0.63% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. USNA Stock News HeadlinesUSANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 1,058 SharesAugust 9, 2025 | insidertrades.comUSANA Health Sciences, Inc. (NYSE:USNA) Insider Sells $106,363.90 in StockAugust 1, 2025 | insidertrades.comWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.August 28 at 2:00 AM | Porter & Company (Ad)USANA Introduces New and Upgraded Products, Along with Its Health Professional Advisory CouncilAugust 22, 2025 | prnewswire.comUSANA's Kevin Guest Shares 7 Daily Habits for Lasting Health, Harmony for National Wellness MonthAugust 4, 2025 | prnewswire.comUSNA Q2 Deep Dive: New Compensation Model and Product Initiatives Drive GrowthJuly 26, 2025 | msn.comUSANA Health Sciences, Inc. (NYSE:USNA) Q2 2025 Earnings Call TranscriptJuly 25, 2025 | msn.comUSANA Health Sciences: Hiya's Potential Is ShowingJuly 24, 2025 | seekingalpha.comSee More Headlines USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $35.89 at the start of the year. Since then, USNA stock has decreased by 12.3% and is now trading at $31.4840. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) released its earnings results on Tuesday, July, 22nd. The company reported $0.74 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.20. The firm earned $235.85 million during the quarter, compared to the consensus estimate of $225.20 million. USANA Health Sciences had a trailing twelve-month return on equity of 9.48% and a net margin of 3.79%. Read the conference call transcript. Who are USANA Health Sciences' major shareholders? Top institutional shareholders of USANA Health Sciences include Pzena Investment Management LLC (6.44%), Geode Capital Management LLC (1.67%), Ameriprise Financial Inc. (0.82%) and Connor Clark & Lunn Investment Management Ltd. (0.52%). Insiders that own company stock include Myron W Wentz, Jim Brown, Kevin Guest, David Mulham Mulham, John Turman Fleming, Peggie Pelosi, Frederic J Winssinger, Xia Ding, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX). Company Calendar Last Earnings7/22/2025Today8/28/2025Next Earnings (Estimated)10/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryPersonal Products Current SymbolNYSE:USNA CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,700Year FoundedN/APrice Target and Rating Average Price Target for USANA Health Sciences$36.00 High Price Target$36.00 Low Price Target$36.00 Potential Upside/Downside+12.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$1.80 Trailing P/E Ratio17.84 Forward P/E Ratio13.11 P/E Growth1.01Net Income$42.03 million Net Margins3.79% Pretax Margin7.18% Return on Equity9.48% Return on Assets6.95% Debt Debt-to-Equity RatioN/A Current Ratio2.15 Quick Ratio1.47 Sales & Book Value Annual Sales$854.50 million Price / Sales0.69 Cash Flow$3.82 per share Price / Cash Flow8.40 Book Value$29.06 per share Price / Book1.10Miscellaneous Outstanding Shares18,270,000Free Float18,157,000Market Cap$586.61 million OptionableOptionable Beta0.61 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:USNA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.